Details for New Drug Application (NDA): 021566

✉ Email this page to a colleague

NDA 021566 describes PREVACID IV, which is a drug marketed by Takeda Pharms Na and is included in one NDA. Additional details are available on the PREVACID IV profile page.

The generic ingredient in PREVACID IV is lansoprazole. There are fifty-six drug master file entries for this compound. Seventy-one suppliers are listed for this compound. Additional details are available on the lansoprazole profile page.

Summary for 021566

Tradename:	PREVACID IV
Applicant:	Takeda Pharms Na
Ingredient:	lansoprazole
Patents:	0

Medical Subject Heading (MeSH) Categories for 021566

Anti-Ulcer Agents
Proton Pump Inhibitors

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INTRAVENOUS			Strength	30MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Approval Date:	May 27, 2004	TE:		RLD:	Yes

Expired US Patents for NDA 021566

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Takeda Pharms Na	PREVACID IV	lansoprazole	INJECTABLE;INTRAVENOUS	021566-001	May 27, 2004	⤷ Subscribe	⤷ Subscribe
Takeda Pharms Na	PREVACID IV	lansoprazole	INJECTABLE;INTRAVENOUS	021566-001	May 27, 2004	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.